Genflow Biosciences Plc

ESEF

5 filing records in this dataset, filed from 2023-07-18 to 2026-05-27. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Insider reports are SEC Forms 3, 4 and 5. This company is not in the SEC regime, so none are shown.

Cash and cash equivalents
112 thousand GBP Source
Exact value

111792 GBP

Long-term debt including current maturities
Not available
Shares outstanding
Not available

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-05-27.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 2 of 11 periods available· newest 2025-12-31
  • Net income: 5 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 5 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 4 of 11 periods available· newest 2024-12-31
  • Total assets: 5 of 11 periods available· newest 2025-12-31
  • Total liabilities: 5 of 11 periods available· newest 2025-12-31
  • Current assets: 5 of 11 periods available· newest 2025-12-31
  • current liabilities: No compatible figures in this window
  • Cash and cash equivalents: 5 of 11 periods available· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    +GBP 169,671

    Prior period

    −GBP 1.59 million

    –

    Current period

    −GBP 1.42 million

    –

    Exact inputs and evidence

    -1417564 − -1587235 = 169671 GBP

    -1587235 GBP · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -1417564 GBP · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −GBP 354,312

    Prior period

    −GBP 1.08 million

    –

    Current period

    −GBP 1.44 million

    –

    Exact inputs and evidence

    -1436585 − -1082273 = -354312 GBP

    -1082273 GBP · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -1436585 GBP · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(GBP)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2021 2021-01-18 – 2021-12-31
−GBP 988,195
Exact value

Exact value: -988195 GBP

2021-01-18 – 2021-12-31: -988195 GBP Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−GBP 747,377
Exact value

Exact value: -747377 GBP

2021-01-18 – 2021-12-31: -747377 GBP Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

GBP 0
Exact value

Exact value: 0 GBP

2021-01-18 – 2021-12-31: 0 GBP Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−GBP 747,377
Calculation and evidence

-747377 − 0 GBP

Exact free cash flow: -747377 GBP

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−GBP 1.34 million
Exact value

Exact value: -1335325 GBP

2022-01-01 – 2022-12-31: -1335325 GBP Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−GBP 1.37 million
Exact value

Exact value: -1368324 GBP

2022-01-01 – 2022-12-31: -1368324 GBP Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

GBP 2,480
Exact value

Exact value: 2480 GBP

2022-01-01 – 2022-12-31: 2480 GBP Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−GBP 1.37 million
Calculation and evidence

-1368324 − 2480 GBP

Exact free cash flow: -1370804 GBP

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−GBP 1.86 million
Exact value

Exact value: -1860345 GBP

2023-01-01 – 2023-12-31: -1860345 GBP Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−GBP 1.66 million
Exact value

Exact value: -1660875 GBP

2023-01-01 – 2023-12-31: -1660875 GBP Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

GBP 2,439
Exact value

Exact value: 2439 GBP

2023-01-01 – 2023-12-31: 2439 GBP Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−GBP 1.66 million
Calculation and evidence

-1660875 − 2439 GBP

Exact free cash flow: -1663314 GBP

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−GBP 1.59 million
Exact value

Exact value: -1587235 GBP

2024-01-01 – 2024-12-31: -1587235 GBP Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−GBP 1.08 million
Exact value

Exact value: -1082273 GBP

2024-01-01 – 2024-12-31: -1082273 GBP Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

GBP 0
Exact value

Exact value: 0 GBP

2024-01-01 – 2024-12-31: 0 GBP Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−GBP 1.08 million
Calculation and evidence

-1082273 − 0 GBP

Exact free cash flow: -1082273 GBP

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−GBP 1.42 million
Exact value

Exact value: -1417564 GBP

2025-01-01 – 2025-12-31: -1417564 GBP Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−GBP 1.44 million
Exact value

Exact value: -1436585 GBP

2025-01-01 – 2025-12-31: -1436585 GBP Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

5 filings · 207 latest values · 207 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 213800HVOFXRXVEGDN62, esef:213800HVOFXRXVEGDN62

Also known as GENFLOW BIOSCIENCES PLC